2012 annual financial data
GT Biopharma, Inc. 2012 Operating margin
GT Biopharma, Inc. 2012 operating margin with verified reported values.
Direct answer
Operating margin was -1,027.49%.
Operating income was -3,514,000 USD and net income was -5,171,000 USD.
Operating cash flow was -987,000 USD.
Get free GT Biopharma, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 342,000 USD
- Operating income
- -3,514,000 USD
- Net income
- -5,171,000 USD
- Operating cash flow
- -987,000 USD